{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T22:38:45Z","timestamp":1786228725015,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Engineering"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.coche.2013.08.009","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T03:16:08Z","timestamp":1379128568000},"page":"425-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Alternative non-antibody protein scaffolds for molecular imaging of cancer"],"prefix":"10.1016","volume":"2","author":[{"given":"Lawrence A","family":"Stern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J","family":"Hackel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coche.2013.08.009_bib0005","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1200\/JCO.2012.42.4887","article-title":"Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncology","volume":"30","author":"Knowles","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coche.2013.08.009_sbref0010","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1535-7163.MCT-09-0195","article-title":"A modeling analysis of the effects of molecular size and binding affinity on tumor targeting","volume":"8","author":"Schmidt","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.coche.2013.08.009_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymeth.2009.03.012","article-title":"Molecular imaging targeting peptide receptors","volume":"48","author":"Schottelius","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.coche.2013.08.009_bib0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-61779-921-1_7","article-title":"Engineering of affibody molecules for therapy and diagnostics","volume":"899","author":"Feldwisch","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.coche.2013.08.009_sbref0025","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-05-3521","article-title":"Tumor imaging using a picomolar affinity HER2 binding affibody molecule","volume":"66","author":"Orlova","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.coche.2013.08.009_bib0030","first-page":"397","article-title":"Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors","volume":"20","author":"Orlova","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0035","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1021\/bc7002617","article-title":"Tc-99m-maEEE-Z(HER2:342), an affibody molecule-based tracer for the detection of HER2 expression in malignant tumors","volume":"18","author":"Tran","year":"2007","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.coche.2013.08.009_bib0040","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00259-007-0658-0","article-title":"[18F]FBEM-ZHER2:342\u2014affibody molecule\u2014a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography","volume":"35","author":"Kramer-Marek","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0045","first-page":"314","article-title":"Evaluation of [(111\/114m)In]CHX-A\u2033-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors","volume":"51","author":"Orlova","year":"2007","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_sbref0050","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2967\/jnumed.108.057919","article-title":"On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124-labeled affibody molecule and trastuzumab in a murine xenograft model","volume":"50","author":"Orlova","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0055","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00259-011-1810-4","article-title":"(68)Ga-DOTA-affibody molecule for in vivo assessment of HER2\/neu expression with PET","volume":"38","author":"Kramer-Marek","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0060","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2967\/jnumed.111.102194","article-title":"HER2-positive tumors imaged within 1hour using a site-specifically 11C-labeled Sel-tagged affibody molecule","volume":"53","author":"W\u00e5llberg","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_sbref0065","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2967\/jnumed.109.073239","article-title":"Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules","volume":"51","author":"Baum","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0070","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2967\/jnumed.108.055525","article-title":"Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry","volume":"50","author":"Tolmachev","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00259-009-1283-x","article-title":"Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount","volume":"37","author":"Tolmachev","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0080","first-page":"853","article-title":"In vivo and in vitro uptake of 111In, delivered with the affibody molecule (ZEGFR:955)2, in EGFR expressing tumour cells","volume":"19","author":"Nordberg","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.coche.2013.08.009_bib0085","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/bc900515p","article-title":"Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein","volume":"21","author":"Miao","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.coche.2013.08.009_bib0090","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2967\/jnumed.111.100842","article-title":"PET of EGFR expression with an 18F-labeled affibody molecule","volume":"53","author":"Miao","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2967\/jnumed.111.090829","article-title":"Imaging of insulinlike growth factor type 1 receptor in prostate cancer xenografts using the affibody molecule 111In-DOTA-ZIGF1R:4551","volume":"53","author":"Tolmachev","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00259-012-2284-8","article-title":"[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours","volume":"40","author":"Orlova","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nucmedbio.2012.12.009","article-title":"Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for in vivo molecular imaging","volume":"40","author":"Honarvar","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.coche.2013.08.009_bib0110","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/cbic.200900062","article-title":"Engineered two-helix small proteins for molecular recognition","volume":"10","author":"Webster","year":"2009","journal-title":"ChemBioChem"},{"key":"10.1016\/j.coche.2013.08.009_bib0115","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.2967\/jnumed.109.064287","article-title":"A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression","volume":"50","author":"Ren","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0120","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-011-1879-9","article-title":"A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor","volume":"38","author":"Miao","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_sbref0125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00259-011-2016-5","article-title":"Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging","volume":"39","author":"Rosik","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-396962-0.00009-4","article-title":"Engineering knottins as novel binding agents","volume":"503","author":"Moore","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.coche.2013.08.009_bib0135","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/0008-5472.CAN-08-2495","article-title":"Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects","volume":"69","author":"Kimura","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.coche.2013.08.009_bib0140","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1021\/bc900361g","article-title":"An engineered knottin peptide labeled with 18F for PET imaging of integrin expression","volume":"20","author":"Miao","year":"2009","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.coche.2013.08.009_sbref0145","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1158\/0008-5472.CAN-10-1338","article-title":"PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide","volume":"70","author":"Nielsen","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.coche.2013.08.009_bib0150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/bc9003102","article-title":"A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects","volume":"21","author":"Kimura","year":"2010","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.coche.2013.08.009_bib0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2967\/jnumed.109.069831","article-title":"Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin","volume":"51","author":"Jiang","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0160","doi-asserted-by":"crossref","first-page":"368075","DOI":"10.1155\/2012\/368075","article-title":"111In-labeled cystine-knot peptides based on the Agouti-related protein for targeting tumor angiogenesis","volume":"2012","author":"Jiang","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.coche.2013.08.009_bib0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00726-012-1391-y","article-title":"A novel radiofluorinated agouti-related protein for tumor angiogenesis imaging","volume":"44","author":"Jiang","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.coche.2013.08.009_bib0170","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1078-0432.CCR-11-1116","article-title":"Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer","volume":"18","author":"Kimura","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coche.2013.08.009_bib0175","unstructured":"Hackel BJ, Kimura RH, Miao Z, Liu H, Sathirachinda A, Cheng Z, Chin FT, Gambhir SS: 18F-labeled cystine knot peptides for PET imaging of integrin \u03b1v\u03b26. J Nucl Med (no date), in press."},{"key":"10.1016\/j.coche.2013.08.009_bib0180","doi-asserted-by":"crossref","first-page":"e60498","DOI":"10.1371\/journal.pone.0060498","article-title":"Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging","volume":"8","author":"Moore","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coche.2013.08.009_bib0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/protein\/gzq097","article-title":"Adnectins: engineered target-binding protein therapeutics","volume":"24","author":"Lipovsek","year":"2011","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.coche.2013.08.009_bib0190","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/B978-0-12-394292-0.00014-X","article-title":"Engineering fibronectin-based binding proteins by yeast surface display","volume":"523","author":"Chen","year":"2013","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.coche.2013.08.009_bib0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1148\/radiol.12111504","article-title":"Use of 64Cu-labeled fibronectin domain with EGFR-overexpressing tumor xenograft: molecular imaging","volume":"263","author":"Hackel","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.coche.2013.08.009_sbref0200","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/protein\/gzs036","article-title":"Designed hydrophilic and charge mutations of the fibronectin domain: towards tailored protein biodistribution","volume":"25","author":"Hackel","year":"2012","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.coche.2013.08.009_bib0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-396962-0.00005-7","article-title":"Designed ankyrin repeat proteins (DARPins) from research to therapy","volume":"503","author":"Tamaskovic","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.coche.2013.08.009_sbref0210","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/0008-5472.CAN-09-2724","article-title":"Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size","volume":"70","author":"Zahnd","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.coche.2013.08.009_bib0215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1158\/1078-0432.CCR-10-1303","article-title":"A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity","volume":"17","author":"Martin-Killias","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.coche.2013.08.009_bib0220","first-page":"198","article-title":"Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma","volume":"48","author":"Li","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11307-008-0172-1","article-title":"Quantitative PET imaging of VEGF receptor expression","volume":"11","author":"Chen","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.coche.2013.08.009_bib0230","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s00259-012-2266-x","article-title":"In vivo characterization of 68Ga-NOTA-VEGF121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models","volume":"40","author":"Kang","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0235","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1522","article-title":"Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes","volume":"13","author":"Backer","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0240","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.nucmedbio.2010.02.001","article-title":"ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature","volume":"37","author":"Eder","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.coche.2013.08.009_bib0245","first-page":"1881","article-title":"Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors","volume":"46","author":"Velikyan","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00259-011-1969-8","article-title":"PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model","volume":"39","author":"Li","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1756-9966-28-136","article-title":"In vivo 99mTc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation","volume":"28","author":"Guo","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.coche.2013.08.009_bib0260","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s11307-012-0551-5","article-title":"Longitudinal PET imaging of doxorubicin-induced cell death with 18F-Annexin V","volume":"14","author":"Hu","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.coche.2013.08.009_bib0265","first-page":"1813","article-title":"Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy","volume":"47","author":"Rottey","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0270","first-page":"3752","article-title":"Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size","volume":"55","author":"Yuan","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.coche.2013.08.009_bib0275","doi-asserted-by":"crossref","first-page":"804","DOI":"10.2967\/jnumed.107.047381","article-title":"Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules","volume":"49","author":"Cheng","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0280","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s00259-008-1003-y","article-title":"Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules","volume":"36","author":"Tolmachev","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0285","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11307-009-0256-6","article-title":"64Cu-labeled affibody molecules for imaging of HER2 expressing tumors","volume":"12","author":"Cheng","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.coche.2013.08.009_bib0290","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2967\/jnumed.111.101527","article-title":"Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition","volume":"53","author":"Tolmachev","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.coche.2013.08.009_bib0295","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1021\/bc800244b","article-title":"Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules","volume":"19","author":"Tran","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.coche.2013.08.009_bib0300","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00259-011-1992-9","article-title":"Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts","volume":"39","author":"Malmberg","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0305","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00259-008-0845-7","article-title":"Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake","volume":"35","author":"Ekblad","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0310","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00259-007-0474-6","article-title":"99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule","volume":"34","author":"Engfeldt","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.coche.2013.08.009_bib0315","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1021\/bc3002369","article-title":"Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules","volume":"23","author":"Perols","year":"2012","journal-title":"Bioconjug Chem"}],"container-title":["Current Opinion in Chemical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211339813000816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211339813000816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T15:16:27Z","timestamp":1761923787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211339813000816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2211339813000816"],"URL":"https:\/\/doi.org\/10.1016\/j.coche.2013.08.009","relation":{},"ISSN":["2211-3398"],"issn-type":[{"value":"2211-3398","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative non-antibody protein scaffolds for molecular imaging of cancer","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Engineering","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coche.2013.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}